An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup

Abstract Ethosuximide, the first‐line therapy for childhood absence epilepsy, is currently formulated as a syrup (Zarontin®, Pfizer) with a bitter taste and high sugar content, poorly adapted to children, and a ketogenic diet. The collaborative European FP7 project KIEKIDS aimed at developing an inn...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Léonore Diezi (Awdur), Kim Dao (Awdur), Vincent Jullien (Awdur), Caroline Roussel‐Maupetit (Awdur), Ingrid Burton (Awdur), Pascal André (Awdur), Carine Bardinet (Awdur), Laura E. Rothuizen (Awdur), Haithem Chtioui (Awdur), Maria A. Manso‐Silvan (Awdur), Catherine Guittet (Awdur), Françoise Brunner‐Ferber (Awdur), Francois Vandenhende (Awdur), Catherine Chiron (Awdur), Luc‐André Granier (Awdur), Thierry Buclin (Awdur)
Fformat: Llyfr
Cyhoeddwyd: Wiley, 2023-02-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg